Zolmitriptan is the generic ingredient in three branded drugs marketed by Astrazeneca, Apotex Inc, Glenmark Generics, Zydus Pharms Usa Inc, Invagen Pharms, Mylan Pharms Inc, Sun Pharma Global, Teva Pharms Usa, and IPR, and is included in twelve NDAs. There are two patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.
There are twenty drug master file entries for zolmitriptan. Five suppliers are listed for this compound.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||Type||RLD||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|TABLET, ORALLY DISINTEGRATING;ORAL||202560||May 14, 2013||RX||No||<disabled>||<disabled>|
|TABLET, ORALLY DISINTEGRATING;ORAL||202476||May 14, 2013||RX||No||<disabled>||<disabled>|
|TABLET, ORALLY DISINTEGRATING;ORAL||021231||Feb 13, 2001||RX||No||<disabled>||<disabled>|
|TABLET, ORALLY DISINTEGRATING;ORAL||021231||Sep 17, 2001||RX||Yes||<disabled>||<disabled>|
|SPRAY;NASAL||021450||Sep 30, 2003||RX||Yes||6,750,237*PED||<disabled>||Y||<disabled>|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.